Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-28

Clinical Trial Update: Effectiveness of Cannabis in the Treatment of Tinnitus Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating cannabis for tinnitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabis (medical cannabis) (cannabis)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Tinnitus | Phase 1 | Status: WITHDRAWN